DeTar Healthcare System is pleased to announce that the upper airway stimulation system, an advanced treatment option for ...

There’s a new landscape of available sleep apnea treatments, something that Robert Miller, an RSPGT, has seen evolve over his long career, which has included ...

Inogen, in partnership with Yuwell, has taken another step toward becoming a comprehensive respiratory solutions company with the launch of its new Aurora line ...

Makatsaria and LivaNova’s leadership outlined the company’s plan for growth during a November Investor Day event. He spoke to ...

These light and fluffy cottage cheese buns are high in protein, low in carbs, and perfect for clean eating. Great as a bread ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...

Obstructive sleep apnea affects the quality of life of millions of people, but current solutions are not always well accepted ...

US price cuts, Medicare expansion, and new oral GLP-1 approvals reshape the competitive outlook for weight-loss drugs.

As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer Interfaces and Neuromodulation.

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.